IMPROVING GLYCAEMIC CONTROL, MINIMISING THE POTENTIAL FOR HYPOGLYCAEMIC-INDUCED MACROVASCULAR COMPLICATIONS

Halban Hall

Tuesday, 29 September 2009, 14:30 - 17:00

Chairman:	Geremia Bolli, IT
14:30 - 14:35	Welcome and introduction Geremia Bolli, IT
14:35 - 15:10	The link between hypoglycaemia and CV risk Vivian Fonseca, US
15:10 - 15:45	Improving α- and β-cell sensitivity to glucose: glycaemic control without hypoglycaemia Bo Ahrén, SE
15:45 - 16:20	Looking to the future: is there evidence for disease modiﬁ cation? Wolfgang E. Schmidt, DE
16:20 - 17:00	Panel discussion All faculty

For further information please contact:

Georgia Harrison
Complete HealthVizion
georgia.harrison@complete-hv.com

or Changsook Connie Kim
Novartis Pharma AG
changsook.kim@novartis.com
Website: www.novartis.com

Sponsor: Novartis